This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aurobindo Pharma Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Srinivasachary Katuroju in Pharmaceutical Chemistry
Introduction
Srinivasachary Katuroju is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work is characterized by a focus on innovative methods that enhance the efficiency and effectiveness of pharmaceutical compounds.
Latest Patents
One of his key patents is titled "Process for the preparation of Dolutegravir." This invention provides a method for synthesizing (R)-3-Amino-1-butanol (D)-tartarate and outlines the process for its conversion to Dolutegravir. The patent also details an improved method for preparing Dolutegravir or its pharmaceutically acceptable salts, wherein compound (XVI) is reacted with an optically active acid addition salt of (R)-3-amino-1-butanol.
Career Highlights
Srinivasachary Katuroju is currently associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company allows him to apply his innovative ideas and contribute to the development of new pharmaceutical products. His expertise in drug formulation and synthesis has positioned him as a valuable asset in the field.
Collaborations
He has collaborated with notable colleagues such as Shankar Reddy Budidet and Jagan Mohan Reddy Sanapureddy. These collaborations have further enriched his research and development efforts, leading to advancements in pharmaceutical processes.
Conclusion
Srinivasachary Katuroju's contributions to pharmaceutical chemistry, particularly through his patent on Dolutegravir preparation, highlight his innovative spirit and dedication to improving drug development processes. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
